高压氧气治疗对非动脉炎中心视网膜动脉阻塞 (HBOT-CRAO) 的影响
Drue M Orwig1, Jianyong Wang2, Zongyuan Li2
1Hyperbaric and Wound Care, Division of Vascular Surgery, Corewell Health West and Michigan State University, Grand Rapids, Michigan, USA.
The American journal of emergency medicine
|August 10, 2025
概括
高压氧气疗法 (HBOT) 在完成完整治疗过程的视网膜中枢动脉封闭 (CRAO) 患者的视力显著改善. 对于在24小时内出现CRAO患者来说,HBOT是安全的,可能是可行的选择.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 高压医学的高压医学.
背景情况:
- 中央视网膜动脉堵塞 (CRAO) 是一种罕见的,破坏性的缺血性中风,导致严重的视力丧失.
- 目前对于CRAO没有指南认可的治疗方法.
- 有限的数据可用于CRAO的高压氧疗法 (HBOT).
研究的目的:
- 研究高压氧化疗 (HBOT) 对非动脉炎性中枢视网膜动脉封闭 (CRAO) 患者的潜在益处.
- 为了评估CRAO患者的视觉结果,这些患者接受了不同持续时间的HBOT.
主要方法:
- 从2019年1月到2024年12月在两个医疗中心对非动脉炎CRAO患者的回顾性研究.
- 患者接受全方位的HBOT (10次5天的治疗),部分的HBOT,如果在24小时治疗窗口之外,则没有HBOT.
- 主要结局:在出院时视觉改善 (LogMAR BCVA),使用t测试,曼-惠特尼U和奇方测试进行分析.
主要成果:
- 在这三个组中没有观察到显著的人口或临床差异.
- 完成完整HBOT疗程的患者表现出明显的视觉改善 (p=0.01).
- 部分或没有HBOT并没有显著改善视力;在HBOT期间发生了一次,没有其他并发症.
结论:
- 完整的HBOT疗程显著改善了非动脉炎CRAO患者的视觉结果.
- 部分或完全没有HBOT治疗没有产生可比的视觉益处.
- 对于CRAO患者来说,HBOT是一种安全的治疗选择,症状出现后24小时内出现.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
319
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
319
Open Angle Glaucoma: Treatment
568
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
568
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
254
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
254
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Angle Closure Glaucoma: Treatment
681
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
681


